Literature DB >> 29920186

Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Ricardo da Silva Antunes1, Mariana Babor1, Chelsea Carpenter1, Natalie Khalil1, Mario Cortese2, Alexander J Mentzer3, Grégory Seumois1, Christopher D Petro4, Lisa A Purcell4, Pandurangan Vijayanand1,5, Shane Crotty1,5, Bali Pulendran2, Bjoern Peters1,5, Alessandro Sette1,5.   

Abstract

In the mid-1990s, whole-cell pertussis (wP) vaccines were associated with local and systemic adverse events that prompted their replacement with acellular pertussis (aP) vaccines in many high-income countries. In the past decade, rates of pertussis disease have increased in children receiving only aP vaccines. We compared the immune responses to aP boosters in individuals who received their initial doses with either wP or aP vaccines using activation-induced marker (AIM) assays. Specifically, we examined pertussis-specific memory CD4+ T cell responses ex vivo, highlighting a type 2/Th2 versus type 1/Th1 and Th17 differential polarization as a function of childhood vaccination. Remarkably, after a contemporary aP booster, cells from donors originally primed with aP were (a) associated with increased IL-4, IL-5, IL-13, IL-9, and TGF-β and decreased IFN-γ and IL-17 production, (b) defective in their ex vivo capacity to expand memory cells, and (c) less capable of proliferating in vitro. These differences appeared to be T cell specific, since equivalent increases of antibody titers and plasmablasts after aP boost were seen in both groups. In conclusion, our data suggest that there are long-lasting effects and differences in polarization and proliferation of T cell responses in adults originally vaccinated with aP compared with those that initially received wP, despite repeated acellular boosters.

Entities:  

Keywords:  Adaptive immunity; Cellular immune response; Immunology; Th1 response; Vaccines

Mesh:

Substances:

Year:  2018        PMID: 29920186      PMCID: PMC6118631          DOI: 10.1172/JCI121309

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  94 in total

1.  Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.

Authors:  E J Ryan; L Nilsson; N Kjellman; L Gothefors; K H Mills
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis.

Authors:  P F M Teunis; O G van der Heijden; H E de Melker; J F P Schellekens; F G A Versteegh; M E E Kretzschmar
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

Review 3.  Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.

Authors:  T Roice Fulton; Varun K Phadke; Walter A Orenstein; Alan R Hinman; Wayne D Johnson; Saad B Omer
Journal:  Clin Infect Dis       Date:  2016-02-07       Impact factor: 9.079

4.  Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

Authors:  B A Halperin; A Morris; D Mackinnon-Cameron; J Mutch; J M Langley; S A McNeil; D Macdougall; S A Halperin
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

5.  BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro.

Authors:  Jeppe Madura Larsen; Christine Stabell Benn; Yvonne Fillie; Desiree van der Kleij; Peter Aaby; Maria Yazdanbakhsh
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

6.  Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes.

Authors:  Shohei Koyama; Taiki Aoshi; Takeshi Tanimoto; Yutaro Kumagai; Kouji Kobiyama; Takahiro Tougan; Kazuo Sakurai; Cevayir Coban; Toshihiro Horii; Shizuo Akira; Ken J Ishii
Journal:  Sci Transl Med       Date:  2010-03-31       Impact factor: 17.956

7.  Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation.

Authors:  Rajesh Ravindran; Nooruddin Khan; Helder I Nakaya; Shuzhao Li; Jens Loebbermann; Mohan S Maddur; Youngja Park; Dean P Jones; Pascal Chappert; Jean Davoust; David S Weiss; Herbert W Virgin; David Ron; Bali Pulendran
Journal:  Science       Date:  2013-12-05       Impact factor: 47.728

8.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

9.  A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Authors:  Manoj Gambhir; Thomas A Clark; Simon Cauchemez; Sara Y Tartof; David L Swerdlow; Neil M Ferguson
Journal:  PLoS Comput Biol       Date:  2015-04-23       Impact factor: 4.475

10.  Automatic Generation of Validated Specific Epitope Sets.

Authors:  Sebastian Carrasco Pro; John Sidney; Sinu Paul; Cecilia Lindestam Arlehamn; Daniela Weiskopf; Bjoern Peters; Alessandro Sette
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

View more
  48 in total

1.  Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Authors:  Stanley A Plotkin
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

2.  Toward a Controlled Human Infection Model of Pertussis.

Authors:  Tod J Merkel
Journal:  Clin Infect Dis       Date:  2020-07-11       Impact factor: 9.079

3.  Highlights of the 12th International Bordetella Symposium.

Authors:  Camille Locht; Nicholas H Carbonetti; James D Cherry; F Heath Damron; Kathryn M Edwards; Rachel Fernandez; Eric T Harvill; Daniela Hozbor; Kingston H G Mills; Maria Eugenia Rodriguez; Françoise Mascart
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

4.  Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Authors:  Ang Lin; Danijela Apostolovic; Maja Jahnmatz; Frank Liang; Sebastian Ols; Teghesti Tecleab; Chenyan Wu; Marianne van Hage; Ken Solovay; Keith Rubin; Camille Locht; Rigmor Thorstensson; Marcel Thalen; Karin Loré
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

5.  The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age.

Authors:  Véronique Schulten; April Frazier; Agustin Calatroni; Meyer Kattan; Leonard B Bacharier; George T O'Connor; Megan T Sandel; Robert A Wood; Lisa M Wheatley; Alkis Togias; Cynthia M Visness; Amy Dresen; James E Gern; Alessandro Sette
Journal:  Clin Exp Allergy       Date:  2019-05-29       Impact factor: 5.018

Review 6.  Pertussis vaccines and protective immunity.

Authors:  Parul Kapil; Tod J Merkel
Journal:  Curr Opin Immunol       Date:  2019-05-09       Impact factor: 7.486

7.  Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.

Authors:  Ricardo da Silva Antunes; Suresh Pallikkuth; Erin Williams; Esther Dawen Yu; Jose Mateus; Lorenzo Quiambao; Eric Wang; Stephen A Rawlings; Daniel Stadlbauer; Kaijun Jiang; Fatima Amanat; David Arnold; David Andrews; Irma Fuego; Jennifer M Dan; Alba Grifoni; Daniela Weiskopf; Florian Krammer; Shane Crotty; Michael E Hoffer; Savita G Pahwa; Alessandro Sette
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

8.  Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.

Authors:  Ricardo da Silva Antunes; Lorenzo G Quiambao; Ferran Soldevila; Aaron Sutherland; Bjoern Peters; Alessandro Sette
Journal:  Cytokine       Date:  2020-09-29       Impact factor: 3.861

9.  A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy.

Authors:  Ricardo da Silva Antunes; Ferran Soldevila; Mikhail Pomaznoy; Mariana Babor; Jason Bennett; Yuan Tian; Natalie Khalil; Yu Qian; Aishwarya Mandava; Richard H Scheuermann; Mario Cortese; Bali Pulendran; Christopher D Petro; Adrienne P Gilkes; Lisa A Purcell; Alessandro Sette; Bjoern Peters
Journal:  JCI Insight       Date:  2021-04-08

10.  Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination.

Authors:  Annieck M Diks; Indu Khatri; Liesbeth E M Oosten; Bas de Mooij; Rick J Groenland; Cristina Teodosio; Martin Perez-Andres; Alberto Orfao; Guy A M Berbers; Jaap Jan Zwaginga; Jacques J M van Dongen; Magdalena A Berkowska
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.